You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Retraction notice to “Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis” [Vascular Pharmacology 113 (2019) 86-91]
|
|---|---|
| Published in |
Vascular Pharmacology, January 2023
|
| DOI | 10.1016/j.vph.2023.107142 |
| Pubmed ID | |
| Authors |
Amr Shaaban Hanafy, Sherief Abd-Elsalam, Mohammed M Dawoud |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 3 | 18% |
| United States | 2 | 12% |
| Canada | 2 | 12% |
| South Africa | 1 | 6% |
| Argentina | 1 | 6% |
| Unknown | 8 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 76% |
| Practitioners (doctors, other healthcare professionals) | 2 | 12% |
| Scientists | 2 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2023.
All research outputs
#4,711,222
of 25,392,582 outputs
Outputs from Vascular Pharmacology
#88
of 1,029 outputs
Outputs of similar age
#95,311
of 475,262 outputs
Outputs of similar age from Vascular Pharmacology
#2
of 6 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 475,262 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.